Bioamber Inc (BIOAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,632 | 10,229 | 5,735 | 14,314 | 25,057 |
| Receivables | 5,252 | 3,010 | 4,191 | 771 | 1,555 |
| Inventories | 4,823 | 6,214 | 4,866 | 4,829 | 4,498 |
| TOTAL | $15,248 | $20,327 | $15,603 | $20,798 | $31,422 |
| Non-Current Assets | |||||
| PPE Net | 49,461 | 127,813 | 123,773 | 121,643 | 121,628 |
| Investments And Advances | 447 | 447 | 447 | 447 | 447 |
| Intangibles | 4,036 | 6,604 | 6,650 | 6,699 | 6,752 |
| Other Non-Current Assets | 322 | 324 | 1,101 | 1,144 | 1,082 |
| TOTAL | $54,266 | $135,188 | $131,971 | $129,934 | $129,909 |
| Total Assets | $69,514 | $155,515 | $147,573 | $150,732 | $161,331 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,920 | 11,789 | 4,266 | 3,474 | 23,299 |
| Accounts payable and accrued liabilities | 6,153 | 6,845 | 5,943 | 4,622 | 6,022 |
| Other current liabilities | N/A | 0 | N/A | 9,324 | 14,497 |
| TOTAL | $11,296 | $18,825 | $10,411 | $17,548 | $45,305 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,696 | 25,409 | 30,928 | 30,210 | 29,032 |
| Deferred Revenues | N/A | 0 | 0 | N/A | 1,372 |
| Other Non-Current Liabilities | 3,670 | 5,277 | 38,978 | 39,362 | 40,367 |
| TOTAL | $36,366 | $29,902 | $68,138 | $68,089 | $67,535 |
| Total Liabilities | $47,661 | $48,727 | $78,549 | $85,636 | $112,840 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 129,451 | 52,115 | 37,102 | 37,074 | 34,850 |
| Common Shares | 996 | 999 | 962 | 1,046 | 1,003 |
| Retained earnings | -318,920 | -234,850 | -227,801 | -220,662 | -220,768 |
| Other shareholders' equity | -12,559 | -10,632 | -10,658 | -12,170 | -12,564 |
| TOTAL | $21,853 | $106,789 | $69,024 | $65,096 | $48,491 |
| Total Liabilities And Equity | $69,514 | $155,515 | $147,573 | $150,732 | $161,331 |